Reference the anomalous disclosure paragraph on Medscape relating to
Peter/Thomas Kramer, I have not yet received a response to my query from
Dr Robert Kennedy, the site director of Medscape, but I also emailed
Thomas A. M. Kramer, who tells me that the disclosure in question relates
to Peter D. Kr
ondon
[EMAIL PROTECTED]
http://www.human-nature.com/esterson/index.html
http://www.butterfliesandwheels.com/articleprint.php?num=10
Mon, 26 Apr 2004 05:53:35 -0400
Author: "Allen Esterson" <[EMAIL PROTECTED]>
Subject: Re: Suicide / Antidepressant
> On 26 April Bill Scott
terson
Former lecturer, Science Department
Southwark College, London
[EMAIL PROTECTED]
http://www.human-nature.com/esterson/index.html
http://www.butterfliesandwheels.com/articleprint.php?num=10
Mon, 26 Apr 2004 10:14:45 -0500
Author: "Stephen Black" <[EMAIL
On 25 Apr 2004, Bill Scott wrote:
>> Paul--
> You are correct, but I would be happy to find more, such as David
> Healy, who refuse to push the party line.
David Healy is famous to Canadian academics but probably less so to
others. So I'd like to recycle a note I wrote to our university
The article was written by Thomas AM Kramer. I will await the information
you receive from medscape.
- Original Message -
From: "Allen Esterson" <[EMAIL PROTECTED]>
To: "Teaching in the Psychological Sciences" <[EMAIL PROTECTED]>
Sent: Monday, April 26, 2
On 26 April Bill Scott wrote:
> Okay, Allen, you make me do my homework.
> Regarding the issues below, this is from Medscape: Go to one of Thomas AM
> Kramer's CME articles at medscape such as:
> http://www.medscape.com/viewarticle/420839
>
> Then click on "disclosures" at the top of the page. Yo
Title: Re: Suicide / Antidepressant
Paul
wrote:
The
real challenge would be to find a pharmacologist (psych or otherwise) who
has not (at least indirectly) received some form of support from the big
pharm.
That's true, of course. But there is quite a bit of diffe
Hi
On Mon, 26 Apr 2004, Rick Adams wrote:
> We all know that our approach to a research project is as important as the
> manner in which we conduct it. Financial considerations can play a part in
> that approach--and thus in the overall results we obtain. I doubt there is
> anyone on this list who
Title: Re: Suicide / Antidepressant
Addendum,
I would also like to add that in regard
to the message that I criticized, Dr. Thomas AM Kramer claimed no drug
company connections, even though he clearly has many and has disclosed them in
other venues when he has been forced to do so. These
What would they win? :) Ok it isn't my main area but Bill's point is well taken. I
suppose I'd be guilty too if you count a few free books or those stupid little foam
objects they hand out or an occasional paid review or grant evaluation. Bill's point,
as I see it, btw, is that it is more a matt
Title: Re: Suicide / Antidepressant
Paul Brandon writes:
Bill--
The real challenge would be to find a pharmacologist (psych or
otherwise) who has not (at least indirectly) received some form of
support from the big pharm.
--
* PAUL K.
BRANDON
Title: Re: Suicide / Antidepressant
At 11:44 AM -0400 4/25/04, Bill Scott wrote:
Okay, Allen, you make me do my
homework.
Regarding the issues below, this is from Medscape: Go to one of Thomas
AM
Kramer's CME articles at medscape such as:
http://www.medscape.com/viewarticle/420839
Then cli
ompanies, I "am sure". Still, thanks for making me provide the evidence for
my conjectures.
Bill Scott
- Original Message -
From: "Allen Esterson" <[EMAIL PROTECTED]>
To: "Teaching in the Psychological Sciences" <[EMAIL PROTECTED]>
Sent: Sunday, Apr
Hi Allen-
Thanks for providing further information about Dr. Kramer. I particularly
enjoyed reading, "Practitioners and the Pharmaceutical Industry ". As
someone who lives with a pharmaceutical sales rep and who has many friends
who are physicians I get to hear both sides of this debate fairly
fre
On 24 April I wrote, quoting Bill Scott first:
> On April 22 Bill Scott wrote:
>
> > Dr. Kramer is a well known advocate of polypharmacy, the giving of multiple
> > drugs to alleviate disorders when single drugs have not been effective. I
> > have not looked up his connections to the drug compani
]>
To: "Teaching in the Psychological Sciences" <[EMAIL PROTECTED]>
Sent: Saturday, April 24, 2004 5:16 AM
Subject: Re: Suicide / Antidepressant
> On April 22 Bill Scott wrote:
>
> > Dr. Kramer is a well known advocate of polypharmacy, the giving of
multiple
> >
On April 22 Bill Scott wrote:
> Dr. Kramer is a well known advocate of polypharmacy, the giving of multiple
> drugs to alleviate disorders when single drugs have not been effective. I
> have not looked up his connections to the drug companies but I am sure he is
> well funded by them. His disclaim
I have inserted my responses to Dr. Kramer (forwarded by Dr. Stonecipher
without critical comment) within the copied (<)message below.
> From C. Stonecipher
> National Park Community College
> Hot Springs, AR.
> [EMAIL PROTECTED]
>
> For those of you interested in the antidepressant / suicide con
>From C. Stonecipher
National Park Community College
Hot Springs, AR.
[EMAIL PROTECTED]
For those of you interested in the antidepressant / suicide concern;
I forward the following:
Medscape Psychopharmacology Today
Talking Points About Antidepressants and Suicide
Thomas A. M. Kramer, MD
Me
19 matches
Mail list logo
